NCT01353963View on ClinicalTrials.gov

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

TerminatedOBSERVATIONAL

Enrollment

13

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Major Depressive DisorderVasomotor Symptoms

Interventions

DRUG

desvenlafaxine succinate

50 mg tablet once daily

Trial Locations (3)

Unknown

Private Clinic, Las Piñas

Private Clinic, Manila

Private Clinic, Pasay

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY